Statement Of Financial Position [Abstract]

Innate Pharma - Filing #858132

Concept As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
Statement of financial position [abstract]
Assets [abstract]
Non-current assets [abstract]
Property, plant and equipment
8 542 EUR
10 174 EUR
Intangible assets other than goodwill
1 556 EUR
44 192 EUR
Trade and other non-current receivables
14 099 EUR
29 821 EUR
Deferred tax assets
8 568 EUR
5 028 EUR
Other non-current non-financial assets
149,000 EUR
148,000 EUR
Non-current assets
68 033 EUR
129 241 EUR
Current assets [abstract]
Trade and other current receivables
38 346 EUR
18 420 EUR
Cash and cash equivalents
84 225 EUR
103 756 EUR
136 792 EUR
Current assets
139 831 EUR
138 256 EUR
Assets
207 863 EUR
267 496 EUR
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
4 011 EUR
3 978 EUR
Share premium
379 637 EUR
375 220 EUR
Other reserves
819,000 EUR
456,000 EUR
Equity
54 151 EUR
58 103 EUR
819,000 EUR
379 637 EUR
272 213 EUR
4 011 EUR
219 404 EUR
EUR
456,000 EUR
EUR
1 054 EUR
107 440 EUR
1 054 EUR
52 809 EUR
EUR
EUR
EUR
EUR
375 220 EUR
3 978 EUR
156 476 EUR
63 984 EUR
3 950 EUR
355,000 EUR
372 131 EUR
155 976 EUR
Liabilities [abstract]
Non-current liabilities [abstract]
Non-current provisions [abstract]
Non-current provisions for employee benefits
2 550 EUR
2 975 EUR
Non-current provisions
198,000 EUR
253,000 EUR
Deferred tax liabilities
8 568 EUR
5 028 EUR
Non-current liabilities
112 374 EUR
80 169 EUR
Current liabilities [abstract]
Current provisions [abstract]
Current provisions
1 542 EUR
647,000 EUR
Trade and other current payables
20 911 EUR
28 573 EUR
Current liabilities
41 338 EUR
79 886 EUR
Equity and liabilities
207 863 EUR
267 496 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.